Company registration number 11114194 (England and Wales)
PORTISHEAD EYECARE LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
PORTISHEAD EYECARE LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
PORTISHEAD EYECARE LIMITED
BALANCE SHEET
AS AT 31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
32,441
11,705
Current assets
Stocks
24,092
24,240
Debtors
4
17,657
17,944
Cash at bank and in hand
4,752
3,502
46,501
45,686
Creditors: amounts falling due within one year
5
(156,324)
(128,603)
Net current liabilities
(109,823)
(82,917)
Total assets less current liabilities
(77,382)
(71,212)
Creditors: amounts falling due after more than one year
6
(41,437)
(62,850)
Net liabilities
(118,819)
(134,062)
Capital and reserves
Called up share capital
7
100
100
Profit and loss reserves
(118,919)
(134,162)
Total equity
(118,819)
(134,062)

For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 23 June 2026
Mr P C Rogers
Director
Company registration number 11114194 (England and Wales)
PORTISHEAD EYECARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 2 -
1
Accounting policies
Company information

Portishead Eyecare Limited is a private company limited by shares incorporated in England and Wales. The registered office is 41 High Street, Portishead, Bristol, BS20 6AA.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Revenue

Turnover represents amounts receivable for goods and services provided in the normal course of business, net of trade discounts, VAT and other sales-related taxes.
Turnover is recognised as earned when, and to the extent that, the company obtains the right to consideration in the exchange for goods and services provided.

Revenue from the sale of spectacles, contact lenses and other related products is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Revenue from the provision of optometry services is recognised when the service is provided.

1.3
Tangible fixed assets

Tangible fixed assets are measured at cost, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Property improvements
20% on cost
Professional Equipment
20% on cost
Computer Equipment
20% on cost
1.4
Stocks

Stocks of spectacles, contact lenses and related products are stated at the lower of cost and estimated selling price less costs to complete and sell.

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

PORTISHEAD EYECARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 3 -
1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

1.6
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

1.7
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.8
Leases
As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
7
7
PORTISHEAD EYECARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 4 -
3
Tangible fixed assets
Property improvements
Professional Equipment
Computer Equipment
Total
£
£
£
£
Cost
At 1 January 2025
184,678
78,798
16,737
280,213
Additions
-
0
28,261
-
0
28,261
At 31 December 2025
184,678
107,059
16,737
308,474
Depreciation and impairment
At 1 January 2025
184,678
73,896
9,934
268,508
Depreciation charged in the year
-
0
4,675
2,850
7,525
At 31 December 2025
184,678
78,571
12,784
276,033
Carrying amount
At 31 December 2025
-
0
28,488
3,953
32,441
At 31 December 2024
-
0
4,902
6,803
11,705
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
12,059
13,301
Other debtors
5,598
4,643
17,657
17,944
5
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
21,048
25,781
Trade creditors
51,043
28,271
Taxation and social security
7,151
5,407
Other creditors
74,447
65,529
Accruals and deferred income
2,635
3,615
156,324
128,603
PORTISHEAD EYECARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 5 -
6
Creditors: amounts falling due after more than one year
2025
2024
Notes
£
£
Bank loans and overdrafts
41,437
62,850
7
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary of £1 each
100
100
100
100
8
Operating lease commitments
As lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2025
2024
£
£
Total commitments
36,000
60,000
9
Related party transactions

During the year, the company loaned money from Rogers Optical Limited, a company with a common director. At the year end, the amount owed to Rogers Optical Limited was £17,809 (2024 - £8,265); t his amount is included in creditors: amounts falling due within one year.

10
Directors' transactions

The company operates a current loan account with its directors. As at 31 December 2025, a balance of £56,638 (2024 - £56,638) was owed from the company to its directors and is included within creditors: amounts falling due within one year.

2025-12-31 2025-01-01 false false false 23 June 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Mr P C Rogers 11114194 2025-01-01 2025-12-31 11114194 2025-12-31 11114194 2024-12-31 11114194 core:LandBuildings 2025-12-31 11114194 core:PlantMachinery 2025-12-31 11114194 core:ComputerEquipment 2025-12-31 11114194 core:LandBuildings 2024-12-31 11114194 core:PlantMachinery 2024-12-31 11114194 core:ComputerEquipment 2024-12-31 11114194 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 11114194 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 11114194 core:Non-currentFinancialInstruments core:AfterOneYear 2025-12-31 11114194 core:Non-currentFinancialInstruments core:AfterOneYear 2024-12-31 11114194 core:ShareCapital 2025-12-31 11114194 core:ShareCapital 2024-12-31 11114194 core:RetainedEarningsAccumulatedLosses 2025-12-31 11114194 core:RetainedEarningsAccumulatedLosses 2024-12-31 11114194 core:ShareCapitalOrdinaryShareClass1 2025-12-31 11114194 core:ShareCapitalOrdinaryShareClass1 2024-12-31 11114194 bus:Director1 2025-01-01 2025-12-31 11114194 core:LandBuildings core:LongLeaseholdAssets 2025-01-01 2025-12-31 11114194 core:PlantMachinery 2025-01-01 2025-12-31 11114194 core:ComputerEquipment 2025-01-01 2025-12-31 11114194 2024-01-01 2024-12-31 11114194 core:LandBuildings core:LeasedAssetsHeldAsLessee 2024-12-31 11114194 core:PlantMachinery 2024-12-31 11114194 core:ComputerEquipment 2024-12-31 11114194 2024-12-31 11114194 core:LandBuildings core:LeasedAssetsHeldAsLessee 2025-12-31 11114194 core:LandBuildings core:LeasedAssetsHeldAsLessee 2025-01-01 2025-12-31 11114194 core:CurrentFinancialInstruments 2025-12-31 11114194 core:CurrentFinancialInstruments 2024-12-31 11114194 core:Non-currentFinancialInstruments 2025-12-31 11114194 core:Non-currentFinancialInstruments 2024-12-31 11114194 bus:OrdinaryShareClass1 2025-01-01 2025-12-31 11114194 bus:OrdinaryShareClass1 2025-12-31 11114194 bus:OrdinaryShareClass1 2024-12-31 11114194 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 11114194 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 11114194 bus:FRS102 2025-01-01 2025-12-31 11114194 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 11114194 bus:FullAccounts 2025-01-01 2025-12-31 xbrli:pure xbrli:shares iso4217:GBP